The present study describes the exploration of small molecules based on heterocyclic scaffolds for tubulin target based development of anticancer agents.
compound reported for a specific biological activity may or may not be limited to that particular activity with a possibility of it to bind at more than one target at molecular level.
Moreover, biological profiles of many compounds in repositories are available in public domain and some of the compounds could be obtained for research purpose. This provides a remarkable and unprecedented support to researchers working in the area of drug development. 7 Chemical compounds with heterocyclic scaffolds form the pivot of pharmaceutical drug industry as well as new drug discovery and development programs for various diseases.
Different heterocyclic moieties are well known for diverse range of pharmacological properties and one of them is nitrogen containing quinazoline pharmacophore. Alkaloids from natural sources contains basic quinazoline skeletal, which is a benzene ring fused to heteroatom containing pyrimidine ring. Peganine is a first quinazoline alkaloid isolated from plant and indolopyridoquinazolinone alkaloid isolated from the plant Evodia rutaecarpa in the early 19 th century is extensively used as tradition medicine for various ailments related to gastro intestine, absence of menstruation, and postpartum haemorrhage in china (Son et al., 2015; Zayed et al., 2015; Kamal et al., 2011) . Extensive reports are available in literature highlighting wide biological activities of quinazoline based derivatives, which includes antimicrobial, anti-inflammatory, anti-malarial, anti HIV, anti-depressant and anti-cancer properties (Kuroiwa et al., 2015) . In recent years, the quinazoline based intermediates are reported to exhibit anti-cancer properties by targeting the mitotic spindle during cell division via inhibition of tubulin polymerization, protein kinase of epidermal growth factor receptor (EGFR) (Wang et al., 2014) Erlotinib and Afatinib, the drugs approved by FDA in 2013 are quinazoline derivatives that target EGFR kinases, thereby preventing the growth of cancer cells (Zahedifard et al., 2015) . Benzothiadiazines, resulting from the addition of a sulphur atom on quinazoline skeleton, are also reported to exhibit wide range of pharmacological potency. 1,2,4-Benzothiadiazine-1,1-dioxide derivatives are used as diuretic medication and recently the moiety has been explored for different pharmacological properties such as antibacterial, antiviral, anticancer, inhibition of ATP-sensitive potassium channel inhibitors and allosteric modulation of AMPA receptors (Sak 2012; Manasa et al., 2011; Nerkar et al., 2009 ).
Exploring heterocylic scaffolds for pharmacological potency in our previous studies, we have synthesized a library of quinazoline and benzothiadiazine derivatives and studied their anti-inflammatory and anti-depressant activities in rats (Reddy et al., 1985 (Reddy et al., , 1987 . Of late in our laboratory, we explore and investigate novel chemical compounds with varied heterocyclic scaffolds for arresting unregulated growth in cancer cells and the mechanism of action of these new entities (Kamal et al., 2007) . The recent advances in the library screening and exploitation of these core moieties have encouraged us to further investigate the quinazoline and benzothiadiazine derivatives stored in our in-house chemical repository for their anticancer activity. For this purpose, we have screened over sixty derivatives for antiproliferative activity against selected human cancer cells to identify promising derivatives. This is followed by mechanistic studies for tubulin polymerization at molecular level for a more focused target based screening for potent anticancer agents.
Microtubule is a dynamic protein made of monomeric α and β tubulin. Many cellular functions are dependent on this microtubule, which includes cell division, cell signalling, cilia and flagellar motions, intracellular transport and intracellular structure etc. Because of its major vital functions in cells it is also called as cytoskeleton and is considered as a desirable target for anticancer agents (Wang and Xie., 2012). In cancer cells, the dynamic stability of tubulin is altered and the tubulin targeting agents act as spindle poison by triggering a mitotic catastrophy resulting in apoptotic cell death. To date several antimitotic compounds are developed which binds to the tubulin at a specific binding site like colchicine, vinca alkaloid, taxol and peloruside binding sites, however most of the compounds bind at colchicine binding site (Wang et al., 2012 (Wang et al., , 2013 .
Results and discussion:
In vitro antiproliferation activity:
From the past few years several research groups are focusing on the quinazoline and benzothiadiazine scaffold to exploit their vast biological activities, especially relating to cancer. This encouraged us to explore the anticancer acitivity of quinazoline (ATS 1-11) and quinazolines exhibited similar activity and many of them are in clinical studies. This encouraged us to select ATS-7 for further biological studies to understand the mechanism of action.
Effect of compounds on tubulin polymerization:
Assay was performed in 384 well black plate contacting 3mg/ml tubulin in the presence of 1 mM GTP and with or without test compound. Fluorescence was measured at 360 nm excitation and 420 nm emission wavelengths. ATS-7 showed 59% tubulin polymerization inhibition at 3 μM concentration whereas the positive control, nocodazole, showed 67% inhibition at the same concentration. Tubulin IC 50 was also determined for this molecule (Figure 1 ).
Cell cycle analysis:
Most of the anticancer agents arrest the cancer cells at a particular cell cycle phase leading to either apoptosis or necrosis, however some drugs directly induce apoptosis. 9, 10 Anti proliferative activity and tubulin inhibition studies revealed that compound ATS-7 showed significant anticancer as well as tubulin inhibition properties. In order to determine whether the effect of ATS-7 on tubulin polymerization inhibition is translated to similar effect in the cancer cells, cell cycle analysis was performed at two different concentrations in time dependent manner. MCF7 cells were treated with the ATS-7 and nocodazole at 0.6 and 
Immunohistochemistry:
Compound ATS-7 with in vitro tubulin inhibition and cell cycle arrest properties, was expected to disrupt microtubules in cells. To demonstrate cellular microtubule disruption, MCF7 cells were grown on coverslips and treated with ATS-7 and nocodazole at 0.6 and 1.2 μM concentration. After 48 h of incubation, cells were fixed and treated with primary anti tubulin and rhodamine conjugated secondary antibodies and DAPI for DNA staining as described in experimental section. These cover slips were mounted on slides and analysed under confocal microscope to photograph the tubulin network in cells. Cells treated with ATS-7 showed altered microtubule network compare to control cells, where well organized microtubule was observed. In both the concentrations ATS-7 and nocodazole both showed disorganized microtubule network at centre of the cells with dense peripheral microtubules ( Figure 3 ). This demonstrated that ATS-7 has antimitotic activity comparable with the positive control nocodazole.
Soluble versus polymerized tubulin analysis by westernblotting:
Inhibition of tubulin polymerization and arrest of cells at G2/M phase in cell cycle analysis was encouraged to analyse the levels of soluble versus polymerized forms of tubulin in MCF7. After incubation of MCF7 cells with compound ATS-7 (0.6 µM and 1.2 µM) for 48 h, cells were washed with PBS and soluble (free tubulin) and insoluble (polymerized form of tubulin as microtubule) fractions were isolated as described in materials and methods section. Nocodazole and taxol (1 µM) was used as tubulin destabilising and stabilising agents (positive and negative controls respectively). Immunoblot was performed with the isolated fractions and results indicate that cells treated with ATS-7 and nocodazole showed increased levels of tubulin in soluble fraction compared to the DMSO control, where as in cells treated with taxol showed increased levels of tubulin polymerised fraction (insoluble fraction) ( Figure 4 ). Results suggest that the compound ATS-7 was a microtubule destabilizing agent.
Mitochondrial membrane potential:
Mitochondria is considered as "power house of cells" but studies on mitochondrial function in cells revealed that they are involved in many cellular activities such as lipid modification, Figure   6 ).
Cooperative index of combination drug treatment:
In this investigation combination treatment was studied and MCF7 cells were treated either in combination or alone with ATS-7, nocodazole and doxorubicin at GI 50 concentration of test compound and it double concentration to get final concentrations of 0.6 and 1.2 μM.
MTT assay was performed after incubating the cells at four different time intervals like 3, 8, 12 and 24 h. Cooperative index is calculated according the formula given in the experimental section and the death percentage of drug combination is represented in figure 7 whereas CI index is presented in table 2. The data demonstrated that at the lower concentration of ATS-7/nocodazole and ATS-7/doxorubicin combinations up to 12 h incubation showed synergistic effect whereas at 24 h of incubation showed antagonistic effect and at higher concentration showed antagonistic effect.
Endocytic pathway of ATS-7:
Bioavailability of drug by cellular uptake and internalization is crucial for its efficacy.
Macromolecules cellular uptake is achieved by various mechanisms and internalized drugs/molecules fate is dependent on its uptake mechanism. Drug transport in to the cells are determined by using endocytic pathway inhibitors. 30 . Many studies revealed that failed or reduced cellular uptake and accumulation of drug is one of the reasons for drug resistance. Romero and co-workers studied the cisplatin and chloride complex cellular uptake mechanism to understand the cellular influx and efflux equilibrium of these anticancer agents in a time dependent manner.
Further, they have also discussed the caveolae mediated endocytosis of these anticancer compounds (Romero et al., 2012). 33 In this connection in the present investigation quinazoline derivative ATS-7 cellular uptake is observed by clathrin mediated endocytosis whereas standard nocodazole cellular uptake is mediated by all three endocytic pathways.
Experimental methods:
In vitro anti-proliferative activity:
Anticancer properties of the selected compounds from in house library were evaluated by a standard sulpha rhodamine B assay (SRB) on a panel of selected human epithelial cancer 
Tubulin polymerization assay:
BK011P kit from Cytoskeleton, Inc. was used to perform fluorescent based tubulin polymerization inhibition assay. According to the manufacturer's protocol inhibitor detection reaction mixture was prepared for a total volume of 10 μl containing 3 mg/ml porcine brain tubulin, 1 mM GTP and a fluorescence reported in PEM buffer at pH -6.9 (80 mM PIPES, 0.5 mM EGTA, 2 mM MgCl2). In the presence and absence of test compounds at a concentration of 3 μM the increase in fluorescence of reaction mixture was measured at 37 ⁰ C at 420 nm emission wavelength by exciting at 360 nm wavelength for every 1 min till 60 min in multimode plate reader. Nocodazole was used as a positive control. Increase in fluorescence was due to the incorporation fluorophore in to the microtubules polymerization.
Tubulin IC 50 was also determined in the same experimental condition as mentioned above. The concentration of compound where 50% of tubulin polymerization was inhibited compared to the control is known as tubulin IC 50 . Various concentrations like 0.5, 1, 3, 6, and 9 μM of compound ATS-7 was added in the reaction mixture. Increase in fluorescence as the polymerization progresses was monitored by tecan multimode plate reader at 37 o C for 1 h at 1 min time interval at 420 nm emission wavelength when excited at 360 nm wave length.
Nocodazole is used as a positive control (Tecan multimode reader) ( 
Immuno cytochemistry:
MCF7 cells at a density of 1 x10 4 cells were seeded on the 18 mm sterile coverslips placed in 6 well plates and incubated for 24 h in a CO 2 incubator. In the presence and absence of the test compound ATS-7 at 0.6 and 1.2 μM concentrations, cells were incubated for 48 h in a CO 2 incubator. Cells were incubated with DAPI for 30 min to stain the DNA. At the termination of experiment, cells were fixed with the mixture of paraformaldehyde, glutaraldehyde solution in 1 ml PBS at a concentration of 3% and 0.02%, respectively for 15 min and permeabilized by dipping them in ice cold 100% methanol for 10 sec. The coverslips were blocked by incubated for 1 h with 1% BSA in PBS and later coverslips were incubated with mouse monoclonal primary anti α tubulin antibody followed by rhodamine conjugated secondary anti-mouse IgG antibody. Coverslips were mounted on a glass slide using DPX fmount and analysed using Nikon A1R confocal microscopy, equipped with rhodamine and DAPI settings. Images were taken at a same scale to analyse the microtubule integrity in test compounds compared to control and positive control nocodazole at 0.6 μM.
Cellular levels of tubulin:
MCF7 cells were seeded in 6-well plates at a density of 2 
Mitochondrial membrane potential:
One of the key functions that altered when the cancer cells are treated with anticancer agents is mitochondrial membrane potential. Most of the anticancer compounds that induce apoptosis will affect the integrity and functioning of mitochondrial membrane. MCF7 cells were analysed for the loss of mitochondrial membrane potential after treatment with the test 
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